logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11413306 B1

PDFFull Text
Date of Patent:
Aug. 16, 2022

Filed:

Oct. 06, 2016

Alginate oligomers for the treatment or prevention of microbial overgrowth in the intestinal tract

Applicant:

Algipharma As, Sandvika, NO;

Inventors:

Arne Dessen, Røyken, NO;

Philip Rye, Eiksmarka, NO;

Assignee:

ALGIPHARMA AS, Sandvika, NO;

Attorney:

Knobbe, Martens, Olson & Bear, LLP

Primary Examiner:

Bahar Craigo

Int. Cl.
CPC ...
A61K 31/734 (2006.01); A61P 31/10 (2006.01); A61K 9/00 (2006.01); A61K 45/06 (2006.01); A61K 31/165 (2006.01); A61K 31/404 (2006.01); A61K 31/415 (2006.01); A61K 31/4375 (2006.01); A61K 31/47 (2006.01); A61K 31/7036 (2006.01); A61K 31/4178 (2006.01); A61K 31/365 (2006.01); A61K 31/4245 (2006.01); A61K 31/352 (2006.01); A61K 31/192 (2006.01); A61K 36/03 (2006.01); A61K 31/522 (2006.01); A61K 31/4422 (2006.01); A61P 31/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/734 (2013.01); A61K 9/0029 (2013.01); A61K 9/0053 (2013.01); A61K 9/0073 (2013.01); A61K 31/165 (2013.01); A61K 31/192 (2013.01); A61K 31/352 (2013.01); A61K 31/365 (2013.01); A61K 31/404 (2013.01); A61K 31/415 (2013.01); A61K 31/4178 (2013.01); A61K 31/4245 (2013.01); A61K 31/4375 (2013.01); A61K 31/4422 (2013.01); A61K 31/47 (2013.01); A61K 31/522 (2013.01); A61K 31/7036 (2013.01); A61K 36/03 (2013.01); A61K 45/06 (2013.01); A61P 31/04 (2018.01); A61P 31/10 (2018.01);
Abstract

The invention provides a method for the treatment or prevention of microbial overgrowth in at least part of the intestinal tract of a subject, said method comprising administering an effective amount of an alginate oligomer to a subject in need thereof. Also provided is an alginate oligomer for use in the treatment or prevention of microbial overgrowth in at least part of the intestinal tract of a subject and a product containing an alginate oligomer and further pharmaceutical for the treatment of intestinal microbial overgrowth and/or a CFTR modulator as a combined preparation for separate, simultaneous or sequential use in the treatment or prevention of microbial overgrowth in at least part of the intestinal tract of a subject.

Find Patent Forward Citations

Loading…